Fighting cancer with a Patient's own supercharged immune cells
Disease control
Terminated
This study tested a personalized cell therapy called LN-145 for women with advanced cervical cancer that had returned, spread, or persisted after other treatments. Doctors collected a patient's own immune cells from her tumor, grew large numbers of them in a lab, and then infused…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC